Anglais

The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 Formulaires  
  1. StudyEvent: SEV1
    1. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    2. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    3. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    9. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    10. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. Subject - Consent Information
    15. Subject - Sample Mapping (including mapping to Coriell IDs)
    16. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    17. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
pht000373.v2.p1
Description

pht000373.v2.p1

DUMMY ID NUMBER
Description

ID2

Type de données

string

MULTIVITAMIN: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

MULTIVYR

Type de données

text

MULTIVITAMIN: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

MULTIVCU

Type de données

text

VITAMIN A IU: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

VAIUYEAR

Type de données

text

VITAMIN A IU: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

VAIUCURR

Type de données

text

VITAMIN A RE: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

VAREYEAR

Type de données

text

VITAMIN A RE: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

VARECURR

Type de données

text

BETA CAROTENE IU: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

BCIUYEAR

Type de données

text

BETA CAROTENE IU: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

BCIUCURR

Type de données

text

BETA CAROTENE MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

BCMGYEAR

Type de données

text

BETA CAROTENE MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

BCMGCURR

Type de données

text

VITAMIN C MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

VITCYEAR

Type de données

text

VITAMIN C MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

VITCCURR

Type de données

text

VITAMIN E IU: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

VEIUYEAR

Type de données

text

VITAMIN E IU: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

VEIUCURR

Type de données

text

VITAMIN E MG: HOW MANY YEARS (ALL PARTICIPANTS)
Description

VEMGYEAR

Type de données

text

VITAMIN E MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

VEMGCURR

Type de données

text

ZINC MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

ZINCYEAR

Type de données

text

ZINC MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

ZINCCURR

Type de données

text

CALCIUM MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

CALCYEAR

Type de données

text

CALCIUM MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

CALCCURR

Type de données

text

IRON MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

IRONYEAR

Type de données

text

IRON MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

IRONCURR

Type de données

text

SELENIUM MCG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
Description

SELEYEAR

Type de données

text

SELENIUM MCG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
Description

SELECURR

Type de données

text

CATARACT SURGERY RT EYE (ALL PARTICIPANTS)
Description

CATSRGQR

Type de données

text

CATARACT SURGERY LT EYE (ALL PARTICIPANTS)
Description

CATSRGQL

Type de données

text

LASER PHOTOCOAGULATION FOR AMD SRNV RT EYE (ALL PARTICIPANTS)
Description

PRVLASQR

Type de données

text

LASER PHOTOCOAGULATION FOR AMD SRNV LT EYE (ALL PARTICIPANTS)
Description

PRVLASQL

Type de données

text

VISUAL ACUITY RT EYE - RANDOMIZATION VISIT (ALL PARTICIPANTS)
Description

ACUIT1RR

Type de données

text

VISUAL ACUITY LT EYE - RANDOMIZATION VISIT (ALL PARTICIPANTS)
Description

ACUIT2RL

Type de données

text

TAKING CENTRUM DURING CLINICAL TRIAL (ALL PARTICIPANTS)
Description

CNTRMTAK

Type de données

text

SEX (ALL PARTICIPANTS)
Description

SEX

Type de données

text

MARITAL STATUS (ALL PARTICIPANTS)
Description

MARITAL

Type de données

text

HIGHEST LEVEL OF SCHOOL ATTENDED (ALL PARTICIPANTS)
Description

SCHOOL

Type de données

text

PRIMARY OCCUPATION (ALL PARTICIPANTS)
Description

OCCUPAT

Type de données

text

RACE OR ETHNIC BACKGROUND (ALL PARTICIPANTS)
Description

RACE

Type de données

text

SITTING SYSTOLIC BLOOD PRESSURE AT BASELINE (ALL PARTICIPANTS)
Description

SITSYST1

Type de données

text

SITTING DIASTOLIC BLOOD PRESSURE AT BASELINE (ALL PARTICIPANTS)
Description

SITDIAS1

Type de données

text

EVER SMOKED CIGARETTES FOR 6 MONTHS OR MORE (ALL PARTICIPANTS)
Description

SMOKEDYN

Type de données

text

AGE STARTED SMOKING (ALL PARTICIPANTS)
Description

SMKAGEST

Type de données

text

AVERAGE PACKS PER DAY SMOKED (ALL PARTICIPANTS)
Description

SMKPACKS

Type de données

text

CURRENTLY SMOKE (ALL PARTICIPANTS)
Description

SMKCURR

Type de données

text

HOW MANY CIGARETTES A DAY SMOKE (ALL PARTICIPANTS)
Description

SMKNOCIG

Type de données

text

AGE QUIT SMOKING (ALL PARTICIPANTS)
Description

SMKAGEQT

Type de données

text

HISTORY OF DIABETES (ALL PARTICIPANTS)
Description

DIABETYN

Type de données

text

AGE DOCTOR FIRST SAID HAD DIABETES (ALL PARTICIPANTS)
Description

DIABAGE

Type de données

text

YEARS TAKING INSULIN FOR DIABETES (ALL PARTICIPANTS)
Description

DIABINS

Type de données

text

YEARS TAKING PILLS FOR DIABETES (ALL PARTICIPANTS)
Description

DIABPILL

Type de données

text

YEARS CONTROLLING DIET FOR DIABETES (ALL PARTICIPANTS)
Description

DIABDIET

Type de données

text

HISTORY OF HIGH BLOOD PRESSURE (ALL PARTICIPANTS)
Description

BPHIGHYN

Type de données

text

CURRENTLY TAKING MEDICATION FOR HIGH BLOOD PRESSURE (ALL PARTICIPANTS)
Description

BPMEDNOW

Type de données

text

HISTORY OF ANGINA (ALL PARTICIPANTS)
Description

ANGINAYN

Type de données

text

HISTORY OF CANCER (ALL PARTICIPANTS)
Description

CANCERYN

Type de données

text

TYPE OF CANCER (ALL PARTICIPANTS)
Description

CANCERTP

Type de données

text

AGE FIRST TOLD HAD CANCER (ALL PARTICIPANTS)
Description

CANCERAG

Type de données

text

HAVE ARTHRITIS (ALL PARTICIPANTS)
Description

ARTHRYN

Type de données

text

AGE FIRST TOLD HAD ARTHRITIS (ALL PARTICIPANTS)
Description

ARTHRAGE

Type de données

text

YEARS TAKING HYDROCHLOROTHIAZIDE (ALL PARTICIPANTS)
Description

HYDROCHL

Type de données

text

YEARS TAKING DIPYRIDAMOLE (ALL PARTICIPANTS)
Description

DIPYRIDA

Type de données

text

YEARS TAKING TRIAMTERENE (ALL PARTICIPANTS)
Description

TRIAMTER

Type de données

text

YEARS TAKING SPIRONOLACTONE (ALL PARTICIPANTS)
Description

SPIRONOL

Type de données

text

YEARS TAKING PROPRANOLOL (ALL PARTICIPANTS)
Description

PROPRANO

Type de données

text

YEARS TAKING OTHER BETA-BLOCKER (ALL PARTICIPANTS)
Description

BETABLOC

Type de données

text

YEARS TAKING CHLORTHALIDONE (ALL PARTICIPANTS)
Description

CHLORTHA

Type de données

text

YEARS TAKING YEARS TAKING FUROSEMIDE (ALL PARTICIPANTS)
Description

FUROSEMI

Type de données

text

YEARS TAKING ACE INHIBITORS (ALL PARTICIPANTS)
Description

ACEINHIB

Type de données

text

YEARS TAKING CALCIUM CHANNEL BLOCKERS (ALL PARTICIPANTS)
Description

CALCBLOC

Type de données

text

YEARS TAKING POTASSIUM CHLORIDE (ALL PARTICIPANTS)
Description

POTASSIU

Type de données

text

YEARS TAKING DIGOXIN (ALL PARTICIPANTS)
Description

DIGOXIN

Type de données

text

YEARS TAKING NITROGLYCERIN (ALL PARTICIPANTS)
Description

NITROGLY

Type de données

text

YEARS TAKING ISOBIDE DINITRATE (ALL PARTICIPANTS)
Description

ISOBDINI

Type de données

text

YEARS TAKING ALLOPURINOL (ALL PARTICIPANTS)
Description

ALLOPURI

Type de données

text

YEARS TAKING BENEMID (ALL PARTICIPANTS)
Description

BENEMID

Type de données

text

YEARS TAKING BLOOD THINNING MEDICATION (ALL PARTICIPANTS)
Description

BLOODTHN

Type de données

text

YEARS TAKING MEDICATION TO LOWER CHOLESTROL OR LIPIDS (ALL PARTICIPANTS)
Description

LOWRCHOL

Type de données

text

YEARS TAKING NONSTEROIDAL ANTI-INFLAMMATORY DRUG (ALL PARTICIPANTS)
Description

ANTIINFL

Type de données

text

YEARS TAKING THYROID HORMONES (ALL PARTICIPANTS)
Description

THYRHORM

Type de données

text

YEARS EVER TAKEN DIURETICS (ALL PARTICIPANTS)
Description

DIURETIC

Type de données

text

CURRENTLY TAKING DIURETICS (ALL PARTICIPANTS)
Description

DIURCURR

Type de données

text

YEARS EVER TAKEN TRANQUILIZERS, ANTIDEPRESSANTS, OR ANTIANXIETY DRUGS (ALL PARTICIPANTS)
Description

TRANQUIL

Type de données

text

CURRENTLY TAKING TRANQUILIZERS (ALL PARTICIPANTS)
Description

TRANCURR

Type de données

text

YEARS EVER TAKEN ASPIRIN OR ASPIRIN PRODUCTS (ALL PARTICIPANTS)
Description

ASPIRIN

Type de données

text

CURRENTLY TAKING ASPIRIN (ALL PARTICIPANTS)
Description

ASPICURR

Type de données

text

YEARS EVER TAKEN ACETAMINOPHEN/TYLENOL (ALL PARTICIPANTS)
Description

ACETAMIN

Type de données

text

CURRENTLY TAKING ACETAMINOPHEN/TYLENOL (ALL PARTICIPANTS)
Description

ACETCURR

Type de données

text

YEARS EVER TAKEN ANTACIDS (ALL PARTICIPANTS)
Description

ANTACID

Type de données

text

CURRENTLY TAKING ANTACIDS (ALL PARTICIPANTS)
Description

ANTACURR

Type de données

text

SITTING SYSTOLIC BLOOD PRESSURE (2ND READING) AT BASELINE (ALL PARTICIPANTS)
Description

SITSYST2

Type de données

text

SITTING DIASTOLIC BLOOD PRESSURE (2ND READING) AT BASELINE (ALL PARTICIPANTS)
Description

SITDIAS2

Type de données

text

APPROXIMATE WEIGHT WHEN 20 YEARS OF AGE (ALL PARTICIPANTS)
Description

WEIGHT20

Type de données

text

OTHER CANCER TYPE (ALL PARTICIPANTS)
Description

MULTSPEC

Type de données

string

AGE AT BASELINE (ALL PARTICIPANTS)
Description

ENROLLAGE

Type de données

float

VISUAL ACUITY RT EYE - QUALIFICATION VISIT (ALL PARTICIPANTS)
Description

QUALVARE

Type de données

text

VISUAL ACUITY LT EYE - QUALIFICATION VISIT (ALL PARTICIPANTS)
Description

QUALVALE

Type de données

text

REFRACTIVE ERROR RT EYE - QUALIFICATION VISIT (ALL PARTICIPANTS)
Description

RE_ERR_Q

Type de données

float

REFRACTIVE ERROR LT EYE - QUALIFICATION VISIT (ALL PARTICIPANTS)
Description

LE_ERR_Q

Type de données

float

REFRACTIVE ERROR RT EYE - RANDOMIZATION VISIT (ALL PARTICIPANTS)
Description

RE_ERR_R

Type de données

float

REFRACTIVE ERROR LT EYE - RANDOMIZATION VISIT (ALL PARTICIPANTS)
Description

LE_ERR_R

Type de données

float

AREDS TREATMENT ASSIGNMENT (ALL PARTICIPANTS)
Description

TRTCAT

Type de données

text

PARTICIPANT AMD CATEGORY AT BASELINE (ALL PARTICIPANTS)
Description

AMDCAT

Type de données

text

BODY-MASS INDEX AT BASELINE (ALL PARTICIPANTS)
Description

BMI_R

Type de données

float

Retour au début de la page

Similar models

The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 Formulaires
  1. StudyEvent: SEV1
    1. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    2. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    3. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    9. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    10. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. Subject - Consent Information
    15. Subject - Sample Mapping (including mapping to Coriell IDs)
    16. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    17. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
pht000373.v2.p1
ID2
Item
DUMMY ID NUMBER
string
Item
MULTIVITAMIN: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
MULTIVYR
Code List
MULTIVITAMIN: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
MULTIVITAMIN: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
MULTIVCU
Code List
MULTIVITAMIN: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
VITAMIN A IU: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
VAIUYEAR
Code List
VITAMIN A IU: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
VITAMIN A IU: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
VAIUCURR
Code List
VITAMIN A IU: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
VITAMIN A RE: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
VAREYEAR
Code List
VITAMIN A RE: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
VITAMIN A RE: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
VARECURR
Code List
VITAMIN A RE: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
BETA CAROTENE IU: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
BCIUYEAR
Code List
BETA CAROTENE IU: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
BETA CAROTENE IU: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
BCIUCURR
Code List
BETA CAROTENE IU: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
BETA CAROTENE MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
BCMGYEAR
Code List
BETA CAROTENE MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
BETA CAROTENE MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
BCMGCURR
Code List
BETA CAROTENE MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
VITAMIN C MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
VITCYEAR
Code List
VITAMIN C MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
VITAMIN C MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
VITCCURR
Code List
VITAMIN C MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
VITAMIN E IU: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
VEIUYEAR
Code List
VITAMIN E IU: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
VITAMIN E IU: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
VEIUCURR
Code List
VITAMIN E IU: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
VITAMIN E MG: HOW MANY YEARS (ALL PARTICIPANTS)
text
VEMGYEAR
Code List
VITAMIN E MG: HOW MANY YEARS (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
VITAMIN E MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
VEMGCURR
Code List
VITAMIN E MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
ZINC MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
ZINCYEAR
Code List
ZINC MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
ZINC MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
ZINCCURR
Code List
ZINC MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
CALCIUM MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
CALCYEAR
Code List
CALCIUM MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
CALCIUM MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
CALCCURR
Code List
CALCIUM MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
IRON MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
IRONYEAR
Code List
IRON MG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
IRON MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
IRONCURR
Code List
IRON MG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
SELENIUM MCG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
text
SELEYEAR
Code List
SELENIUM MCG: HOW MANY YEARS (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
Less than 1 yr (1)
CL Item
1-2 yrs (2)
CL Item
3-5 yrs (3)
CL Item
6-9 yrs (4)
CL Item
10+ yrs (5)
CL Item
Never taken (missing)
Item
SELENIUM MCG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
text
SELECURR
Code List
SELENIUM MCG: CURRENTLY TAKING (AS OF BASELINE) (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Never taken (X)
CL Item
Yes (Y)
Item
CATARACT SURGERY RT EYE (ALL PARTICIPANTS)
text
CATSRGQR
Code List
CATARACT SURGERY RT EYE (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
CATARACT SURGERY LT EYE (ALL PARTICIPANTS)
text
CATSRGQL
Code List
CATARACT SURGERY LT EYE (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
LASER PHOTOCOAGULATION FOR AMD SRNV RT EYE (ALL PARTICIPANTS)
text
PRVLASQR
Code List
LASER PHOTOCOAGULATION FOR AMD SRNV RT EYE (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Questionable (Q)
CL Item
Yes (Y)
Item
LASER PHOTOCOAGULATION FOR AMD SRNV LT EYE (ALL PARTICIPANTS)
text
PRVLASQL
Code List
LASER PHOTOCOAGULATION FOR AMD SRNV LT EYE (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Questionable (Q)
CL Item
Yes (Y)
ACUIT1RR
Item
VISUAL ACUITY RT EYE - RANDOMIZATION VISIT (ALL PARTICIPANTS)
text
ACUIT2RL
Item
VISUAL ACUITY LT EYE - RANDOMIZATION VISIT (ALL PARTICIPANTS)
text
Item
TAKING CENTRUM DURING CLINICAL TRIAL (ALL PARTICIPANTS)
text
CNTRMTAK
Code List
TAKING CENTRUM DURING CLINICAL TRIAL (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
SEX (ALL PARTICIPANTS)
text
SEX
Code List
SEX (ALL PARTICIPANTS)
CL Item
Female (F)
CL Item
Male (M)
Item
MARITAL STATUS (ALL PARTICIPANTS)
text
MARITAL
Code List
MARITAL STATUS (ALL PARTICIPANTS)
CL Item
Married (1)
CL Item
Divorced/separated (2)
CL Item
Widowed (3)
CL Item
Never married (4)
Item
HIGHEST LEVEL OF SCHOOL ATTENDED (ALL PARTICIPANTS)
text
SCHOOL
Code List
HIGHEST LEVEL OF SCHOOL ATTENDED (ALL PARTICIPANTS)
CL Item
Grade 11 or less (1)
CL Item
High school graduate (2)
CL Item
Some college or associate degree (3)
CL Item
Bachelor's degree (4)
CL Item
Postgraduate work (5)
CL Item
Refused to answer (6)
Item
PRIMARY OCCUPATION (ALL PARTICIPANTS)
text
OCCUPAT
Code List
PRIMARY OCCUPATION (ALL PARTICIPANTS)
CL Item
Managerial or professional specialty (1)
CL Item
Technical, Sales, or administrative support (2)
CL Item
Service occupation (3)
CL Item
Farming, forestry, or fishing (4)
CL Item
Precision production, craft or repair (5)
CL Item
Operator, fabricator, or laborer (6)
CL Item
Military (7)
CL Item
Nonworker (8)
CL Item
Refused to answer (9)
Item
RACE OR ETHNIC BACKGROUND (ALL PARTICIPANTS)
text
RACE
Code List
RACE OR ETHNIC BACKGROUND (ALL PARTICIPANTS)
CL Item
White - not of Hispanic origin (1)
CL Item
Black - not of Hispanic origin (2)
CL Item
Hispanic (3)
CL Item
Asian or Pacific Islander (4)
CL Item
Other (5)
SITSYST1
Item
SITTING SYSTOLIC BLOOD PRESSURE AT BASELINE (ALL PARTICIPANTS)
text
SITDIAS1
Item
SITTING DIASTOLIC BLOOD PRESSURE AT BASELINE (ALL PARTICIPANTS)
text
Item
EVER SMOKED CIGARETTES FOR 6 MONTHS OR MORE (ALL PARTICIPANTS)
text
SMOKEDYN
Code List
EVER SMOKED CIGARETTES FOR 6 MONTHS OR MORE (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
SMKAGEST
Item
AGE STARTED SMOKING (ALL PARTICIPANTS)
text
Item
AVERAGE PACKS PER DAY SMOKED (ALL PARTICIPANTS)
text
SMKPACKS
Code List
AVERAGE PACKS PER DAY SMOKED (ALL PARTICIPANTS)
CL Item
Less than or equal to 0.5 pack (1)
CL Item
More than 0.5, less than or equal to 1 pack (2)
CL Item
More than 1, less than or equal to 2 packs (3)
CL Item
More than 2 packs (4)
Item
CURRENTLY SMOKE (ALL PARTICIPANTS)
text
SMKCURR
Code List
CURRENTLY SMOKE (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
SMKNOCIG
Item
HOW MANY CIGARETTES A DAY SMOKE (ALL PARTICIPANTS)
text
SMKAGEQT
Item
AGE QUIT SMOKING (ALL PARTICIPANTS)
text
Item
HISTORY OF DIABETES (ALL PARTICIPANTS)
text
DIABETYN
Code List
HISTORY OF DIABETES (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
DIABAGE
Item
AGE DOCTOR FIRST SAID HAD DIABETES (ALL PARTICIPANTS)
text
Item
YEARS TAKING INSULIN FOR DIABETES (ALL PARTICIPANTS)
text
DIABINS
Code List
YEARS TAKING INSULIN FOR DIABETES (ALL PARTICIPANTS)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING PILLS FOR DIABETES (ALL PARTICIPANTS)
text
DIABPILL
Code List
YEARS TAKING PILLS FOR DIABETES (ALL PARTICIPANTS)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS CONTROLLING DIET FOR DIABETES (ALL PARTICIPANTS)
text
DIABDIET
Code List
YEARS CONTROLLING DIET FOR DIABETES (ALL PARTICIPANTS)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
HISTORY OF HIGH BLOOD PRESSURE (ALL PARTICIPANTS)
text
BPHIGHYN
Code List
HISTORY OF HIGH BLOOD PRESSURE (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY TAKING MEDICATION FOR HIGH BLOOD PRESSURE (ALL PARTICIPANTS)
text
BPMEDNOW
Code List
CURRENTLY TAKING MEDICATION FOR HIGH BLOOD PRESSURE (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA (ALL PARTICIPANTS)
text
ANGINAYN
Code List
HISTORY OF ANGINA (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF CANCER (ALL PARTICIPANTS)
text
CANCERYN
Code List
HISTORY OF CANCER (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
TYPE OF CANCER (ALL PARTICIPANTS)
text
CANCERTP
Code List
TYPE OF CANCER (ALL PARTICIPANTS)
CL Item
Breast (1)
CL Item
Colon/rectum (2)
CL Item
Lung (3)
CL Item
Prostate (4)
CL Item
Melanoma (5)
CL Item
Basal or squamous cell skin cancer (6)
CL Item
Other malignancy (7)
CL Item
Multiple types (8)
CANCERAG
Item
AGE FIRST TOLD HAD CANCER (ALL PARTICIPANTS)
text
Item
HAVE ARTHRITIS (ALL PARTICIPANTS)
text
ARTHRYN
Code List
HAVE ARTHRITIS (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
ARTHRAGE
Item
AGE FIRST TOLD HAD ARTHRITIS (ALL PARTICIPANTS)
text
Item
YEARS TAKING HYDROCHLOROTHIAZIDE (ALL PARTICIPANTS)
text
HYDROCHL
Code List
YEARS TAKING HYDROCHLOROTHIAZIDE (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING DIPYRIDAMOLE (ALL PARTICIPANTS)
text
DIPYRIDA
Code List
YEARS TAKING DIPYRIDAMOLE (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING TRIAMTERENE (ALL PARTICIPANTS)
text
TRIAMTER
Code List
YEARS TAKING TRIAMTERENE (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING SPIRONOLACTONE (ALL PARTICIPANTS)
text
SPIRONOL
Code List
YEARS TAKING SPIRONOLACTONE (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING PROPRANOLOL (ALL PARTICIPANTS)
text
PROPRANO
Code List
YEARS TAKING PROPRANOLOL (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING OTHER BETA-BLOCKER (ALL PARTICIPANTS)
text
BETABLOC
Code List
YEARS TAKING OTHER BETA-BLOCKER (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING CHLORTHALIDONE (ALL PARTICIPANTS)
text
CHLORTHA
Code List
YEARS TAKING CHLORTHALIDONE (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING YEARS TAKING FUROSEMIDE (ALL PARTICIPANTS)
text
FUROSEMI
Code List
YEARS TAKING YEARS TAKING FUROSEMIDE (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING ACE INHIBITORS (ALL PARTICIPANTS)
text
ACEINHIB
Code List
YEARS TAKING ACE INHIBITORS (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING CALCIUM CHANNEL BLOCKERS (ALL PARTICIPANTS)
text
CALCBLOC
Code List
YEARS TAKING CALCIUM CHANNEL BLOCKERS (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING POTASSIUM CHLORIDE (ALL PARTICIPANTS)
text
POTASSIU
Code List
YEARS TAKING POTASSIUM CHLORIDE (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING DIGOXIN (ALL PARTICIPANTS)
text
DIGOXIN
Code List
YEARS TAKING DIGOXIN (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING NITROGLYCERIN (ALL PARTICIPANTS)
text
NITROGLY
Code List
YEARS TAKING NITROGLYCERIN (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING ISOBIDE DINITRATE (ALL PARTICIPANTS)
text
ISOBDINI
Code List
YEARS TAKING ISOBIDE DINITRATE (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING ALLOPURINOL (ALL PARTICIPANTS)
text
ALLOPURI
Code List
YEARS TAKING ALLOPURINOL (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING BENEMID (ALL PARTICIPANTS)
text
BENEMID
Code List
YEARS TAKING BENEMID (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING BLOOD THINNING MEDICATION (ALL PARTICIPANTS)
text
BLOODTHN
Code List
YEARS TAKING BLOOD THINNING MEDICATION (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING MEDICATION TO LOWER CHOLESTROL OR LIPIDS (ALL PARTICIPANTS)
text
LOWRCHOL
Code List
YEARS TAKING MEDICATION TO LOWER CHOLESTROL OR LIPIDS (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING NONSTEROIDAL ANTI-INFLAMMATORY DRUG (ALL PARTICIPANTS)
text
ANTIINFL
Code List
YEARS TAKING NONSTEROIDAL ANTI-INFLAMMATORY DRUG (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING THYROID HORMONES (ALL PARTICIPANTS)
text
THYRHORM
Code List
YEARS TAKING THYROID HORMONES (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS EVER TAKEN DIURETICS (ALL PARTICIPANTS)
text
DIURETIC
Code List
YEARS EVER TAKEN DIURETICS (ALL PARTICIPANTS)
CL Item
Not taking (0)
CL Item
Less than 5 years (1)
CL Item
Equal to or more than 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
CURRENTLY TAKING DIURETICS (ALL PARTICIPANTS)
text
DIURCURR
Code List
CURRENTLY TAKING DIURETICS (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
YEARS EVER TAKEN TRANQUILIZERS, ANTIDEPRESSANTS, OR ANTIANXIETY DRUGS (ALL PARTICIPANTS)
text
TRANQUIL
Code List
YEARS EVER TAKEN TRANQUILIZERS, ANTIDEPRESSANTS, OR ANTIANXIETY DRUGS (ALL PARTICIPANTS)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
CURRENTLY TAKING TRANQUILIZERS (ALL PARTICIPANTS)
text
TRANCURR
Code List
CURRENTLY TAKING TRANQUILIZERS (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
YEARS EVER TAKEN ASPIRIN OR ASPIRIN PRODUCTS (ALL PARTICIPANTS)
text
ASPIRIN
Code List
YEARS EVER TAKEN ASPIRIN OR ASPIRIN PRODUCTS (ALL PARTICIPANTS)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
CURRENTLY TAKING ASPIRIN (ALL PARTICIPANTS)
text
ASPICURR
Code List
CURRENTLY TAKING ASPIRIN (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
YEARS EVER TAKEN ACETAMINOPHEN/TYLENOL (ALL PARTICIPANTS)
text
ACETAMIN
Code List
YEARS EVER TAKEN ACETAMINOPHEN/TYLENOL (ALL PARTICIPANTS)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
CURRENTLY TAKING ACETAMINOPHEN/TYLENOL (ALL PARTICIPANTS)
text
ACETCURR
Code List
CURRENTLY TAKING ACETAMINOPHEN/TYLENOL (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
Item
YEARS EVER TAKEN ANTACIDS (ALL PARTICIPANTS)
text
ANTACID
Code List
YEARS EVER TAKEN ANTACIDS (ALL PARTICIPANTS)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less than 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
CURRENTLY TAKING ANTACIDS (ALL PARTICIPANTS)
text
ANTACURR
Code List
CURRENTLY TAKING ANTACIDS (ALL PARTICIPANTS)
CL Item
No (N)
CL Item
Yes (Y)
SITSYST2
Item
SITTING SYSTOLIC BLOOD PRESSURE (2ND READING) AT BASELINE (ALL PARTICIPANTS)
text
SITDIAS2
Item
SITTING DIASTOLIC BLOOD PRESSURE (2ND READING) AT BASELINE (ALL PARTICIPANTS)
text
WEIGHT20
Item
APPROXIMATE WEIGHT WHEN 20 YEARS OF AGE (ALL PARTICIPANTS)
text
MULTSPEC
Item
OTHER CANCER TYPE (ALL PARTICIPANTS)
string
ENROLLAGE
Item
AGE AT BASELINE (ALL PARTICIPANTS)
float
QUALVARE
Item
VISUAL ACUITY RT EYE - QUALIFICATION VISIT (ALL PARTICIPANTS)
text
QUALVALE
Item
VISUAL ACUITY LT EYE - QUALIFICATION VISIT (ALL PARTICIPANTS)
text
RE_ERR_Q
Item
REFRACTIVE ERROR RT EYE - QUALIFICATION VISIT (ALL PARTICIPANTS)
float
LE_ERR_Q
Item
REFRACTIVE ERROR LT EYE - QUALIFICATION VISIT (ALL PARTICIPANTS)
float
RE_ERR_R
Item
REFRACTIVE ERROR RT EYE - RANDOMIZATION VISIT (ALL PARTICIPANTS)
float
LE_ERR_R
Item
REFRACTIVE ERROR LT EYE - RANDOMIZATION VISIT (ALL PARTICIPANTS)
float
Item
AREDS TREATMENT ASSIGNMENT (ALL PARTICIPANTS)
text
TRTCAT
Code List
AREDS TREATMENT ASSIGNMENT (ALL PARTICIPANTS)
CL Item
Placebo (1)
CL Item
Antioxidants (2)
CL Item
Zinc (3)
CL Item
Antioxidants+Zinc (4)
Item
PARTICIPANT AMD CATEGORY AT BASELINE (ALL PARTICIPANTS)
text
AMDCAT
Code List
PARTICIPANT AMD CATEGORY AT BASELINE (ALL PARTICIPANTS)
CL Item
AMD Category 1 (1)
CL Item
AMD Category 2 (2)
CL Item
AMD Category 3a (3a)
CL Item
AMD Category 3b (3b)
CL Item
AMD Category 4a (4a)
CL Item
AMD Category 4b (4b)
BMI_R
Item
BODY-MASS INDEX AT BASELINE (ALL PARTICIPANTS)
float
Retour au début de la page